1. Available at: http://www.cdc.gov/tobacco/factsheets/Tobacco_Related_Mortality_factsheet.htm. Accessed December 12, 2005.
2. Kang SY, Seeram NP, Nair MG, Bourquin LD. Tart cherry anthocyanins inhibit tumor development in Apc(Min) mice and reduce proliferation of human colon cancer cells. Cancer Lett. 2003 May 8;194(1):13-9.
3. Pratico D, Tillmann C, Zhang ZB, Li H, FitzGerald GA. Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice. Proc Natl Acad Sci USA. 2001 Mar 13;98(6):3358-63.
4. Tall JM, Seeram NP, Zhao C, et al. Tart cherry anthocyanins suppress inflammation-induced pain behavior in rat. Behav Brain Res. 2004 Aug 12;153(1):181-8.
5. Wang H, Nair MG, Strasburg GM, et al. Cyclooxygenase active bioflavonoids from Balaton tart cherry and their structure activity relationships. Phytomedicine. 2000 Mar;7(1):15-9.
6. Seeram NP, Momin RA, Nair MG, Bourquin LD. Cyclooxygenase inhibitory and antioxidant cyanidin glycosides in cherries and berries. Phytomedicine. 2001 Sep;8(5):362-9.
7. Wang H, Nair MG, Strasburg GM, et al. Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherries. J Nat Prod. 1999 Feb;62(2):294-6.
8. Kolayli S, Kucuk M, Duran C, Candan F, Dincer B. Chemical and antioxidant properties of Laurocerasus officinalis Roem. (cherry laurel) fruit grown in the Black Sea region. J Agric Food Chem. 2003 Dec 3;51(25):7489-94.
9. Wakabayashi H, Fukushima H, Yamada T, et al. Inhibition of LPS-stimulated NO production in mouse macrophage-like cells by Barbados cherry, a fruit of Malpighia emarginata DC. Anticancer Res. 2003 Jul;23(4):3237-41.
10. Nagamine I, Akiyama T, Kainuma M, et al. Effect of acerola cherry extract on cell proliferation and activation of ras signal pathway at the promotion stage of lung tumorigenesis in mice. J Nutr Sci Vitaminol (Tokyo). 2002 Feb;48(1):69-72.
11. Jacob RA, Spinozzi GM, Simon VA, et al. Consumption of cherries lowers plasma urate in healthy women. J Nutr. 2003 Jun;133(6):1826-9.
12. Rimm EB, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med. 1996 Sep 1;125(5):384-9.
13. Burkhardt S, Tan DX, Manchester LC, Hardeland R, Reiter RJ. Detection and quantification of the antioxidant melatonin in Montmorency and Balaton tart cherries (Prunus cerasus). J Agric Food Chem. 2001 Oct;49(10):4898-902.
14. Available at: http://pubs.acs.org/pressrelease/jafc/release3.html. Accessed December 15, 2005.
15. Available at: http://www.wholehealthmd.com/print/view/1,1560,SU_10015,00.html. Accessed December 15, 2005.
16. Available at: http://www.wjla.com/news/stories/1005/272655.html. Accessed December 15, 2005.
17. Available at: http://www.fda.gov/bbs/topics/news/2005/new01246.html. Accessed December 15, 2005.
18. Available at: http://www.cfsan.fda.gov/~dms/chrylist.html. Accessed December 15, 2005.
19. Available at: http://aspartametruth.com/ blaylock/interaction.html. Accessed December 15, 2005.
20. Available at: http://www.inmotionmagazine.com/ geff4.html. Accessed December 15, 2005.
21. Sasso FC, Carbonara O, Nasti R, et al. Glucose metabolism and coronary heart disease in patients with normal glucose tolerance. JAMA. 2004 Apr 21;291(15):1857-63.
22. Reiser S. Effect of dietary sugars on metabolic risk factors associated with heart disease. Nutr Health. 1985;3(4):203-16.
23. Pamplona R, Bellmunt MJ, Portero M, Prat J. Mechanisms of glycation in atherogenesis. Med Hypotheses. 1993 Mar;40(3):174-81.
24. Reyes FG, Valim MF, Vercesi AE. Effect of organic synthetic food colours on mitochondrial respiration. Food Addit Contam. 1996 Jan;13(1):5-11.
25. Jagerstad M, Skog K. Genotoxicity of heat-processed foods. Mutat Res. 2005 Jul 1;574(1-2):156-72.
26. Sasaki YF, Kawaguchi S, Kamaya A, et al. The comet assay with 8 mouse organs: results with 39 currently used food additives. Mutat Res. 2002 Aug 26;519(1-2): 103-19.
27. Tsuda S, Murakami M, Matsusaka N, et al. DNA damage induced by red food dyes orally administered to pregnant and male mice. Toxicol Sci. 2001 May;61(1):92-9.
28. Ashida H, Hashimoto T, Tsuji S, Kanazawa K, Danno G. Synergistic effects of food colors on the toxicity of 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole (Trp-P-1) in primary cultured rat hepatocytes. J Nutr Sci Vitaminol (Tokyo). 2000 Jun;46(3):130-6.
29. Tjaderhane L, Larmas M. A high sucrose diet decreases the mechanical strength of bones in growing rats. J Nutr. 1998 Oct;128(10):1807-10.
30. Veromann S, Sunter A, Tasa G, et al. Dietary sugar and salt represent real risk factors for cataract development. Ophthalmologica. 2003 Jul;217(4):302-7.
31. Michaud DS, Liu S, Giovannucci E, et al. Dietary sugar, glycemic load, and pancreatic cancer risk in a prospective study. J Natl Cancer Inst. 2002 Sep 4;94(17):1293-300.
32. Molteni R, Barnard RJ, Ying Z, Roberts CK, Gomez-Pinilla F. A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning. Neuroscience. 2002;112(4):803-14.
33. Blacklock NJ. Sucrose and idiopathic renal stone. Nutr Health. 1987;5(1-2):9-17.
34. Moerman CJ, Bueno de Mesquita HB, Runia S. Dietary sugar intake in the aetiology of biliary tract cancer. Int J Epidemiol. 1993 Apr;22(2):207-14.
35. Kruis W, Forstmaier G, Scheurlen C, Stellaard F. Effect of diets low and high in refined sugars on gut transit, bile acid metabolism, and bacterial fermentation. Gut. 1991 Apr;32(4):367-71.
36. Yudkin J, Eisa O. Dietary sucrose and oestradiol concentration in young men. Ann Nutr Metab. 1988;32(2):53-5.
37. De Stefani E, Deneo-Pellegrini H, Mendilaharsu M, Ronco A, Carzoglio JC. Dietary sugar and lung cancer: a case-control study in Uruguay. Nutr Cancer. 1998;31(2):132-7.
38. Available at: http://www.fda.gov/foi/warning_letters/g5531d.htm. Accessed December 15, 2005.
39. Available at: http://www.fda.gov/opacom/morechoices/mission.html. Accessed December 15, 2005.
40. Available at: http://www.finance.senate.gov/ sitepages/hearing111804.htm. Accessed December 15, 2005.
41. Available at: http://thomas.loc.gov/. Accessed December 15, 2005.
42. Available at: http://www.house.gov/ paul/congrec/congrec2005/cr111005.htm. Accessed December 15, 2005.
43. Available at: http://www.fda.gov/opacom/laws/dshea.html. Accessed December 15, 2005.
44. Available at: http://www.arthritis.org/ resources/arthritistoday/2002_archives/2002_09_10_OnCall.asp. Accessed December 15, 2005.
45. Blando F, Gerardi C, Nicoletti I. Sour cherry (Prunus cerasus L) anthocyanins as ingredients for functional foods. J Biomed Biotechnol. 2004;2004(5):253-8.
46. Martinez B. Novartis fights eczema drug's cancer warning. Wall Street Journal. April 8, 2005.
47. Bresalier RS, Sandler RS, Quan H, et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med. 2005 Mar 17;352(11):1092-102.
48. Topol EJ. Failing the public healthrofecoxib, Merck, and the FDA. N Engl J Med. 2004 Oct 21;351(17):1707-9.
49. Martinez B. Merck documents shed light on Vioxx legal battles. Wall Street Journal. February 7, 2005. |